Get Premium to unlock powerful stock data
NYSE:GSK (UK)  
GSK PLC logo

GSK PLC

$ 43.89 +0.195 (+0.45%) 11:25 AM EST
On watch
P/E:
17.44
P/B:
5.48
Market Cap:
$ 111.42B
Enterprise V:
$ 133.18B
Volume:
1.44M
Avg Vol (2M):
6.21M
Also Trade In:
Volume:
1.44M
Market Cap $:
111.42B
PE Ratio:
17.44
Avg Vol (2-Month):
6.21M
Enterprise Value $:
133.18B
PB Ratio:
5.48
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.

Financials (Next Earnings Date:2022-07-28 Est.)

GSK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:GSK

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 49,371.894
EPS (TTM) ($) 2.738
Beta 0.7
Volatility % 16.99
14-Day RSI 53.85
14-Day ATR ($) 0.832047
20-Day SMA ($) 42.9205
12-1 Month Momentum % 13.35
52-Week Range ($) 37.7999 - 46.97
Shares Outstanding (Mil) 2,542.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GSK PLC Filings

Document Form Filing Date
No Filing Data

Headlines

See More